Reports for KBI Biopharma SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About KBI Biopharma SA
- KBI Biopharma SA has its legal headquarters in Plan-les-Ouates and is active. It operates in the sector «Research and development».
- The management of the company KBI Biopharma SA consists of 10 persons. The foundation of the company took place on 23.09.2020.
- On the 01.02.2024 the commercial register entry of the company was last changed. Under «Notifications» you will find all changes.
- KBI Biopharma SA is registered in the Canton of GE under the UID CHE-379.634.011.
Management (10)
newest board members
newest authorized signatories
Antony Said Fraij,
Argiñe Pereda Cortazar,
Jean-François Zawieja,
Mary Kay Marchigiani,
Sigma Mostafa
Commercial register information
Entry in the commercial register
23.09.2020
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Plan-les-Ouates
Commercial Registry Office
GE
Commercial register number
CH-660.2.998.020-7
UID/VAT
CHE-379.634.011
Sector
Research and development
Purpose (Original language)
Commercialiser et fournir des services de développement et fabrication sous contrat et des services connexes à l'industrie biopharmaceutique (cf. statuts pour but complet).
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| RSM Audit Switzerland SA | Genève | 28.09.2020 | ||
Other company names
Es sind keine früheren oder übersetzten Firmannamen vorhanden.
Would you like to update the company name? Click here.Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: KBI Biopharma SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1005950579, Commercial Registry Office Geneva, (660)
KBI Biopharma SA, à Plan-les-Ouates, CHE-379.634.011 (FOSC du 08.09.2023, p. 0/1005834593). Signature collective à deux a été conférée à Fraij Antony Said, des USA, à Erie, OH, USA, Marchigiani Mary Kay, des USA, à Rockville, MD, USA, Mostafa Sigma, des USA, à Cary, NC, USA, Pereda Cortazar Argiñe, d'Espagne, à Epalinges, et Zawieja Jean-François, de France, à Carouge (GE).
Publication number: HR02-1005834593, Commercial Registry Office Geneva, (660)
KBI Biopharma SA, à Plan-les-Ouates, CHE-379.634.011 (FOSC du 09.12.2022, p. 0/1005625267). Mowery Jeffrey Daniel, des USA, à Snohomish, USA, est membre président du conseil d'administration avec signature individuelle.
Publication number: HR02-1005625267, Commercial Registry Office Geneva, (660)
KBI Biopharma SA, à Plan-les-Ouates, CHE-379.634.011 (FOSC du 11.11.2022, p. 0/1005602872). Womack Mark n'est plus administrateur;
ses pouvoirs sont radiés. Lowery Marshall Timothy, des USA, à Roxboro, USA, est administrateur unique avec signature individuelle.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.